The use of patient induced pluripotent stem cells (iPSC) heralds the emergence of new technologies that present opportunities from studying the biological mechanisms at the origins of metal health to development of new therapies, diagnostics and precision medicine.

These approaches closely interface with the needs of the individual patient and hence it is essential to work within an appropriate ethical framework. MINDDS has conducted a review of iPSC activity for the study of neurodevelopmental disorders (NDD).

This workshop aims to propose and discuss a MINDDS code of ethics for iPSC-based studies.